In this randomised non-blinded trial , patients between 1 and 21 years old , receiving low/moderate intensity chemotherapy were pre-consented and , on presentation to emergency ( ED ) with FN satisfying low risk criteria , randomised to either outpatient or inpatient care with intravenous cefepime 50mg/kg ( 12 hourly ) .